Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009;41(3):344-90.
doi: 10.1080/10837450902891295.

Drug metabolism and pharmacokinetics

Affiliations
Review

Drug metabolism and pharmacokinetics

Margherita Strolin Benedetti et al. Drug Metab Rev. 2009.

Abstract

In this article, aspects of absorption, distribution, metabolism, and excretion have been described bearing in mind the pathogenesis of allergic diseases and their possible therapeutic opportunities. The importance of the routes of administration of the different therapeutic groups has been emphasized. The classical aspects of drug metabolism and disposition related to oral administration have been reviewed, but special emphasis has been given to intranasal, cutaneous, transdermal, and ocular administration as well as to the absorption and the subsequent bioavailability of drugs. Drug-metabolizing enzymes and transporters present in extrahepatic tissues, such as nasal mucosa and the respiratory tract, have been particularly discussed. As marketed antiallergic drugs include both racemates and enantiomers, aspects of stereoselective absorption, distribution, metabolism, and excretion have been discussed. Finally, a new and promising methodology, microdosing, has been presented, although it has not yet been applied to drugs used in the treatment of allergic diseases.

PubMed Disclaimer

Similar articles

  • From pharmacokinetics to therapeutics.
    Church MK, Gillard M, Sargentini-Maier ML, Poggesi I, Campbell A, Benedetti MS. Church MK, et al. Drug Metab Rev. 2009;41(3):455-74. doi: 10.1080/10837450902891535. Drug Metab Rev. 2009. PMID: 19601722 Review.
  • Therapeutic management of allergic diseases.
    Watelet JB, Gillard M, Benedetti MS, Lelièvre B, Diquet B. Watelet JB, et al. Drug Metab Rev. 2009;41(3):301-43. doi: 10.1080/10837450902891204. Drug Metab Rev. 2009. PMID: 19601717 Review.
  • Gender and interindividual variability in pharmacokinetics.
    Nicolas JM, Espie P, Molimard M. Nicolas JM, et al. Drug Metab Rev. 2009;41(3):408-21. doi: 10.1080/10837450902891485. Drug Metab Rev. 2009. PMID: 19601720 Review.
  • Pharmacokinetics in special populations.
    Poggesi I, Benedetti MS, Whomsley R, Le Lamer S, Molimard M, Watelet JB. Poggesi I, et al. Drug Metab Rev. 2009;41(3):422-54. doi: 10.1080/10837450902891527. Drug Metab Rev. 2009. PMID: 19601721 Review.
  • Drug interactions.
    Boobis A, Watelet JB, Whomsley R, Benedetti MS, Demoly P, Tipton K. Boobis A, et al. Drug Metab Rev. 2009;41(3):486-527. doi: 10.1080/10837450902891550. Drug Metab Rev. 2009. PMID: 19601724 Review.

Cited by

MeSH terms

LinkOut - more resources